MA (Massachusetts) Fat Grafting

Fat Grafting Related Terms:
Fat Grafting In MA Massachusetts, MA Adipose Tissue, MA Body Procedures, MA Cosmetic Surgery, MA Fat, MA Fat Graft, MA Fat Injections, MA Fat Removal, MA Fat Transfer, MA Fatty Tissue, MA Plastic Surgery

Plastic Surgery Your Procedure Procedure Animation

Fat Grafting in MA section, includes general infrmation about Fat Grafting Procedure, Fat Grafting MA Local News, Fat Grafting MA Surgeon Locator and other Fat Grafting related material.

Fat Grafting Procedure

As we grow older our face become more and more affected by the sun, gravity and use of expression muscles (chewing, smiling, etc). Deep tissues loose the ability to maintain a young look and expression marks appear on our faces. Fat grafting can help you fill the defects and regain younger appearance. It can be used to fill expression folds, sunken checks, scars and lips. This procedure is not sufficient to treat deep defects like multiple grooves around the mouse of heavy smokers. It can be done as isolated treatment or as a combination with laser, facelift and botox.

During the procedure the surgeon performs a liposuction from various body parts like thighs, tummy and buttocks and then injects the fat into selected areas needs to be filled. After disinfection of the donor and recipient areas, they are being sedated using local anesthetics. Sedative drugs also can be used, if so you may need an escort to avoid driving under their influence. For liposuction the surgeon uses wide needle or canola. After a short treatment the fat is injected to the desired site. The recipient area is usually bandaged. In order to fill sunken chicks often over filling is required because of absorption process of some of the fat injected. This can make your face appear over swollen immediately after the operation.

If the area treated is extensive it is advisable to restrain from activities after the treatment. Although most of the patients can go back to their daily activities right away. There might be redness, swelling and small hemorrhages around both the donor and the recipient sites. The severity of those symptoms usually depends on the magnitude of the procedure. It is advisable to avoid sun exposure until the above disappear (after approximately 48 hours). There is no limitation to use make-up. The swelling can last for weeks especially if the area is large. Every operation has its ricks. The fat being taken from the patient`s body doesn`t cause allergic responses. There is a small chance of infection.

You must remember that the effect of the injection is only temporary. Due to their biological nature the injected materials disassemble by the body. The duration of the effect depends on genetics, age, skin quality, life style and the area being filled. There are selected cases where the results lasted for a year, but in most cases half of the effect disappears after 3-6 month.

Other Fat Grafting Procedures
All Face Procedures
Fat Grafting MA (current)
Fat Grafting MA BOTOX® Cosmetic
Fat Grafting MA Ear Surgery
Fat Grafting MA Facelift
Fat Grafting MA Browlift

Plastic Surgery Your Procedure Procedure Animation

Planing on having fat grafting procedure in MA?
Here is some General Information about MA:

Massachusetts Cities

There are 351 cities and towns in Massachusetts. The 10 largest cities are:

Boston - The state capital and largest city.
Brockton - "The City of Champions".
Cambridge - Home to Harvard University and MIT.
Fall River
New Bedford - "The Whaling City"
Quincy - "City of Presidents".
MA fat grafting - Tip of the day:
Are there any limitations of the individuals who opt for Fat Grafting?
The individual who prefers to undergo this surgery should be physically healthy and fit and should not have diabetes, hyper tension or any other chronic disease. He/she should also be mentally prepared for the change. The doctors at MA(Massachusetts) suggest that patients also have realistic expectations so they can emotionally cope well with the changes post surgery.

MA fat grafting - News update:

Context  Gene expression profiling may be useful for prognostic and therapeutic strategies in breast carcinoma.

Objectives  To demonstrate the value in integrating genomic information with clinical and pathological risk factors, to refine prognosis, and to improve therapeutic strategies for early stage breast cancer.

Design, Setting, and Patients  Retrospective study of patients with early stage breast carcinoma who were candidates for adjuvant chemotherapy; 964 clinically annotated breast tumor samples (573 in the initial discovery set and 391 in the validation cohort) with corresponding microarray data were used. All patients were assigned relapse risk scores based on their respective clinicopathological features. Signatures representing oncogenic pathway activation and tumor biology/microenvironment status were applied to these samples to obtain patterns of deregulation that correspond with relapse risk scores to refine prognosis with the clinicopathological prognostic model alone. Predictors of chemotherapeutic response were also applied to further characterize clinically relevant heterogeneity in early stage breast cancer.

Main Outcome Measures  Gene expression signatures and clinicopathological variables in early stage breast cancer to determine a refined estimation of relapse-free survival and sensitivity to chemotherapy.

Results  In the initial data set of 573 patients, prognostically significant clusters representing patterns of oncogenic pathway activation and tumor biology/microenvironment states were identified within the low-risk (log-rank P = .004), intermediate-risk (log-rank P = .01), and high-risk (log-rank P = .003) model cohorts, representing clinically important genomic subphenotypes of breast cancer. As an example, in the low-risk cohort, of 6 prognostically significant clusters, patients in cluster 4 had an inferior relapse-free survival vs patients in cluster 1 (log-rank P = .004) and cluster 5 (log-rank P = .03). Median relapse-free survival for patients in cluster 4 was 16 months less than for patients in cluster 1 (95% CI, 7.5-24.5 months) and 19 months less than for patients in cluster 5 (95% CI, 10.5-27.5 months). Multivariate analyses confirmed the independent prognostic value of the genomic clusters (low risk, P = .05; high risk, P = .02). The reproducibility and validity of these patterns of pathway deregulation in predicting relapse risk was established using related but not identical clusters in the independent validation cohort. The prognostic clinicogenomic clusters also have unique sensitivity patterns to commonly used cytotoxic therapies.

Conclusions  These results provide preliminary evidence that incorporation of gene expression signatures into clinical risk stratification can refine prognosis. Prospective studies are needed to determine the value of this approach for individualizing therapeutic strategies.


Fat Grafting Services & Sponsored links in MA

Plastic Surgery Articles

Find more Fat Grafting locations in MA

Find more services in MA: